Filana Therapeutics, Inc. Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss
Filana Therapeutics, Inc. (FLNA) reported Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss of $0 for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-07-19.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2016-07-19
- Filana Therapeutics, Inc. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2016-06-30 was $0.00.
- Filana Therapeutics, Inc. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2016-03-31 was $0.00.
- Filana Therapeutics, Inc. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2015-09-30 was $0.00.
- Filana Therapeutics, Inc. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2013-06-30 was $0.00.
- Filana Therapeutics, Inc. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for fiscal 2012 was $0.00.
| Period end | Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss 3 month | Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 month | Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss 9 month | Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss 12 month |
|---|---|---|---|---|
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-19 | $0.00 10-Q · filed 2016-07-19 | ||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | ||
| 2015-06-30 | $0.00 10-Q · filed 2015-07-23 | |||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $0.00 10-Q · filed 2013-08-01 | $0.00 derived: sum of 3 quarters · filed 2013-08-01 | |
| 2013-03-31 | $0.00 10-Q · filed 2013-04-24 | $0.00 derived: sum of 2 quarters · filed 2013-04-24 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-08 | $0.00 10-K · filed 2013-02-08 | ||
| 2012-09-30 | $0.00 10-Q · filed 2012-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |